MITD1 deficiency leads to poor survival via tissue factor-mediated coagulation in bladder cancer

CONCLUSIONS: Our findings suggest the novel role of tumor prognostic genes upon the development of hypercoagulative phenotype and venous thromboembolism, thereby underlining the importance of anticoagulant therapy and shedding light on the therapeutic value of targeting MITD1 in bladder cancer.PMID:38554936 | DOI:10.1016/j.jtha.2024.03.015

Source: Thrombosis and Haemostasis - March 30, 2024 Category: Hematology Authors: Yuanbin Chen Wei Jiao Yonghua Wang Zhijuan Liang Liping Wang Dan Li Ye Liang Haitao Niu Source Type: research